Publications Archive - 2020

Recent Posts

PLOS One: Crowdfunding for complementary and alternative medicine: What are cancer patients seeking?

Complementary and alternative medicine (CAM) is increasingly being integrated into conventional medical care for cancer, used to counter the side...

RSC Policy Briefing: Let's Do Better: Public Representations of COVID-19 Science

COVID science is being both done and circulated at a furious pace. While it is inspiring to see the research community responding so vigorously to...

BMJ: COVID-19 and ‘immune boosting’ on the internet: a content analysis of Google search results

The spread of misinformation has accompanied the coronavirus pandemic, including topics such as immune boosting to prevent COVID-19. This study...

Medical Law International: The legal and policy considerations of transplanting pediatric thymus regulatory T cells as an immunotherapy in Canada

Regulatory T cells (Tregs) hold promise for cell-based therapies for autoimmunity and transplant rejection. In Canada, the potential collection,...

Obstetrics and Gynaecology: Discussing NIPT on Reddit: The benefits, the concerns, the comradery

As the use of Non‐Invasive Prenatal Testing (NIPT) increases, its benefits and concerns are being examined through surveys, qualitative studies and...

American Journal of Public Health: Crowdfunding Cannabidiol (CBD) for Cancer: Hype and Misinformation on GoFundMe

Misinformation around CBD for cancer is widespread on medical crowdfunding campaigns. Given the potential adverse impact, crowdfunding platforms,...

Bio Med Central: “Immune Boosting” in the time of COVID: selling immunity on Instagram

The concept of “immune boosting” is scientifically misleading and often used to market unproven products and therapies. This paper presents an...

Taylor & Francis Online: The consumer representation of DNA ancestry testing on YouTube

Ancestry testing and personal social media accounts were commonly promoted, demonstrating biotechnological hype where promotion abounds and...

Does Debunking Work? Correcting COVID-19 Misinformation on Social Media

BMC Medical Ethics: The law and problematic marketing by private umbilical cord blood banks

Private umbilical cord blood banking is a for-profit industry in which parents pay to store blood for potential future use. Governments have noted...

OSF PrePrints: Does Debunking Work? Correcting COVID-19 Misinformation on Social Media

One of the defining characteristics of this pandemic has been the spread of misinformation. Indeed, the World Health Organization famously called...

JOGC: Non-Invasive Prenatal Screening: Navigating the Relevant Legal Norms

In sum, the law will define and bound the acceptable behaviour of physicians recommending or administering NIPS, and nudge the technology's...

Nature: Pseudoscience and COVID-19 — we’ve had enough already

The scientific community must take up cudgels in the battle against bunk.

Érudit: Research, Digital Health Information and Promises of Privacy: Revisiting the Issue of Consent

L’obligation de préserver la vie privée des patients et des participants à la recherche est fondamentale en recherche biomédicale.

Canadian Journal of Kidney Health and Disease: Policy Challenges for Organ Allocation in an Era of "Precision Medicine"

March 20, 2020 Timothy Caulfield, Blake Murdoch, Ruth Sapir-Pichhadze, Paul Keown

Policy Options: misinformation, alternative medicine and the coronavirus

Alternative medicine practitioners are leveraging the fear around coronavirus to sell products and procedures that are scientifically unproven.

Future Medicine: Portrayal of umbilical cord blood research in the North American popular press: promise or hype?

Findings demonstrate the need for continual monitoring of the media portrayals of UCB as stem cell and transplantation research develops and as...

Journal of the Canadian Association of Gastroenterology: The Law and Ethics of Switching from Biologic to Biosimilar in Canada

An in depth look in the implementation of nonmedical/'forced' switches by cutting drug coverage for reference biologics and funding only less...